Chair:  Maribel Salas, MD, DSc, MSc Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania and Medical Director, United States Patient Safety, AstraZeneca, Wilmington, Delaware.

Leadership Group:
Abhijit Gadkari PhD, RPh, Manager, US Outcomes Research, Merck & Co., Inc., Philadelphia, PA, USA   
Anuja Roy  PhD, MBA , Senior Manager, Global Health Economics & Outcomes Research, Takeda Pharmaceuticals International, Inc, Deerfield IL, USA
Dyfrig Hughes PhD, MSc, Reader in Pharmacoeconomics, Bangor University Centre for Economics and
Policy in Health, IMSCaR, Bangor, Wales, UK      
Elizabeth Manias RN, BPharm, MPharm, MNStud, PhD, FRCNA, MPS, Professor, Associate Head of
Research, School of Nursing and Social Work, Faculty of Medicine, Dentistry and Health Sciences,
The University of Melbourne, Carlton, Victoria, Australia            
Ian Barron PhD, PharmD,  Research Fellow, University of Dublin, Trinity College Department of
Pharmacology & Therapeutics, Dublin, Ireland 
John Zeber PhD, MHA, Investigator / Assistant Professor, Veterans Affairs HSRD, San Antonio, TX, USA               
Katarzyna Kolasa PhD, HEOS Manager for Poland and Central Europe, Bristol-Myers Squibb, 
Warsaw, Poland
Lincy Lal Pharm.D, PhD, Senior Research Consultant – Healthcare, Ingenix Consulting, Missouri City,
TX, USA
Mickaël Hiligsmann MPH, MSc, PhD Student, University of Liège HEC-School of Management,
Liège, Belgium
Monali Bhosle PhD, MS, Consultant, Health Economics & Outcomes Research, IMS Consulting,
Falls Church, VA, USA         
Peter Dale MSc, BSc, Manager GHO, GlaxoSmithKline, Uxbridge, UK      
Scott Leslie MPH, Statistician, Prescription Solutions, Costa Mesa, CA, USA        
Stacey Guy BSocSci, Hons Psych, Masters Psych, Research Assistant, I-THINK Research Lawson
Health Research Institute, 801 Commissioners Rd E, Suite B3041, London, Ontario, Canada
Vernon Schabert PhD, BA, Principal, Health Economics and Outcomes Research IMS Health, Santa Barbara, CA, USA
Veronica Decker MBA, RN, Researcher, Michigan State University, Troy, MI, USA

Objectives:
Develop standards for analyses of medication compliance and treatment persistence and their relationship to health outcomes.

Activities:

• Medication compliance in breast cancer treatment
  Description: Systematic literature review to examine compliance in breast cancer patients.
  Project Co‐Leaders: Lincy Lal and Monali Bhosle
  Proposed methodology: Interventions to improve patient compliance with oral chemotherapy and hormonal therapy in breast cancer will be examined. Qualitative and quantitative analysis will be conducted to determine which interventions have a positive impact on improving compliance. TrialStat SRS will be utilized for the analysis. The review process will consist of three levels of inclusion/exclusion determination with two reviewers per study at each level. TrialStat SRS will be utilized for the analysis. Qualitative and quantitative analysis will be conducted to determine which interventions have a positive impact on improving compliance.
  Project start date: In progress
  
  
• Interventions for self‐management: recommendations for good practices
  Description: With the increased burden of health care resources, self‐management is being touted as an important strategy to improve compliance. There are many definitions around self‐management strategies and interventions which have varied results. A review of strategies and their respective success or failures will be examined.
  Project Leader: Femida Gwadry‐Sridhar
  Proposed methodology: Using a systematic review we will expand on our previous research to consider interventions that are used for self‐management.
  1) We will look at what types of interventions are used and whether the interventions differ by disease
  2) We will assess the efficacy or effectiveness of self‐management strategies on compliance and possibly clinical outcomes, if they are reported.
  3) Make recommendations for future prospective research
  Project start date: TBD
  
  
• Hypertension paper
  Paper is in the process of completion.  Paper is intended for submission to the “Journal of Hypertension”.
  
  
• Dyslipidemia paper
  A review of compliance interventions in patients with dyslipidemia was carried out.  An abstract was submitted for ISPOR 15th International Meeting and will be presented in a poster session.  A manuscript is under preparation.
  
  
• Respiratory Infection paper
  Group plans to finish the paper by September 2010.
  
  
• Osteoporosis paper
  Systematic literature review is being updated. Analysis is planned by June. The team plans to submit the paper before the end of 2010.